Mandy Parrett - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Mandy Parrett's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Mandy Parrett

Mandy Parrett

Verified

Sub Editor, Russell Publishing, Drug Target Review

Tonbridge

Final Covers

anything wine related

Doesn’t Cover

Blockchain. Anything not tech.

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 423

  • Chemokines work undercover as drivers of autoimmune disease

    By Mandy Parrett Verified| Drug Target Review Verified New research has uncovered a hitherto unknown mechanism whereby chemokines form DNA-bound nanoparticles that play a key role in autoimmune disorders. Just when you think you understand which molecules do what – scientists uncover new surprises that shift the landscape of our comprehension of diseases.

    By Mandy Parrett Verified · Drug Target Review

    Jul. 18, 2022

  • Soft nickases could be the future of safe, effective gene editing

    By Mandy Parrett Verified| Drug Target Review Verified Researchers in the US have developed a new CRISPR method for treating genetic conditions using nickases that they say is safer and more effective. The capability to edit mutations in genetic sequences was a ground-breaking discovery, which over the last decade has enjoyed various applications in both the health and food industries.

    By Mandy Parrett Verified · Drug Target Review

    Jul. 04, 2022

  • Chemokines work undercover as drivers of autoimmune disease

    By Mandy Parrett Verified| Drug Target Review Verified New research has uncovered a hitherto unknown mechanism whereby chemokines form DNA-bound nanoparticles that play a key role in autoimmune disorders. Just when you think you understand which molecules do what – scientists uncover new surprises that shift the landscape of our comprehension of diseases.

    By Mandy Parrett Verified · Drug Target Review

    Jul. 18, 2022

As seen in

Company Info

Drug Target Review

Drug Target Review is a media platform dedicated to drug discovery and therapeutic development. It provides high-quality content, analysis, and networking opportunities for professionals in the pharmaceutical and biotech industries. Operating under Russell Publishing, it shares expertise with its sister publication, European Pharmaceutical Review. The platform features peer-written articles from respected scientists, creating a community for academia, research facilities, and industry professionals. The services offered include a quarterly journal with peer-reviewed articles, a digital platform with access to webinars and news updates, and annual workshops and conferences for knowledge exchange. Drug Target Review has a robust membership base, with free subscriptions to print and digital magazines, e-newsletters, and exclusive website access. It also offers integrated marketing solutions, including digital advertising and custom content creation, to enhance brand awareness and thought leadership in the industry.

'+44 19 5956 3311

Founded: 2014